Enzyme Linked Immunosorbent Assay (ELISA) Market, 2020-2027 – Market Outlook, Competitive Analysis, Industry Trends: Coherent Market Insights

Scope of the Enzyme Linked Immunosorbent Assay (ELISA) Market

The primary focus of the market is to provide a comprehensive analysis of the Enzyme Linked Immunosorbent Assay (ELISA) Market with corresponding stats, diagrams, and factual information. This includes qualitative and quantitative analysis such as SWOT analysis, PEST analysis, and Porter’s five force analysis. The report profiles key players in the market and offers detailed insight into their product portfolio, manufacturing plants, revenue generation, geographical presence, key developments, and growth strategies. It also offers key insights into market segmentation on regional as well as country level.

Request PDF Brochure For More Details With Analysis @ https://www.coherentmarketinsights.com/insight/request-pdf/1505

Dynamics/Drivers

Enzyme Linked Immunosorbent Assay (ELISA) is immunoassay used to identify proteins, peptides, antibodies, and hormones. ELISA assay has application in biotechnology medicine, as a diagnostic tool, which detects color change to identify a target substance and measures its concentration in the test sample. The common diagnostic applications of ELISA are HIV infection, pregnancy tests, and measurement of cytokines, soluble proteins, and others. Various antigen-antibody combinations are used in the immunoassay that include an enzyme-labeled antigen or antibody and enzyme activity is measured.

On the basis of antigen-antibody combination, the assay is segmented in to direct ELISA, indirect ELISA, sandwich ELISA, and competitive ELISA. Increasing prevalence of infectious disease such as HIV and increasing awareness regarding diagnosis of cancer and autoimmune diseases are major factors propelling demand for ELISA to reduce the burden of chronic diseases with early and accurate disease diagnosis. For instance, According to Centers of Disease Control & Prevention (CDC), 2014, number of patients infected with HIV in the U.S. was 37,600. The CDC also reported a decline of 10% in the incidence rate of HIV as compared to 2010, owing to early detection and advanced diagnostic.

The global Enzyme Linked Immunosorbent Assay (ELISA) Market was valued at US$ 1,583.4 million in 2017 and is expected to witness a robust CAGR of 5.1% over the forecast period (2017 - 2025).

Buy This Premium Research Report: https://www.coherentmarketinsights.com/promo/buynow/1505

Major Players Are - Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc., Thermo Fisher Scientific, Inc., Biomerieux S.A., Alpco, BioLegand, Inc., Zeus Scientific, Inc., and Shenzhen YHLO Biotech Co., Ltd.

Contact Us:

Name: Mr. ShahPhone: US +12067016702 / UK +4402081334027Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.